Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic | SCAI
Clinical Documents SCAI Endorsed icon

Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic

SCAI-Endorsed Documents Cath Lab Administration Occupational Health and Well-Being Quality Improvement

From the North American Society Leadership

In this consensus report, we harmonize recommendations from North American CV societies and provide guidance on the safe reintroduction of invasive CV procedures and diagnostic tests after the initial peak of the COVID-19 pandemic.

All authors: David A. Wood, MD, FSCAI; Ehtisham Mahmud, MD, MSCAI; Vinod H. Thourani, MD; Janarthanan Sathananthan, MD, MBChB, MPH; Alice Virani, MA, MS, MPH, PhD; Athena Poppas, MD; Robert A. Harrington, MD, FSCAI; Joseph A. Dearani, MD; Madhav Swaminathan, MD; Andrea M. Russo, MD; Ron Blankstein, MD; Sharmila Dorbala, MD; James Carr, MD; Sean Virani, MD, MSc, MPH; Kenneth Gin, MD; Alan Packard, PhD; Vasken Dilsizian, MD; Jean-François Légaré, MD;  Jonathon Leipsic, MD; John G. Webb, MD; and Andrew D. Krahn, MD.

Other Guidance Documents

Evidence-based recommendations that promote optimal patient care based on current state-of-the-art science in interventional cardiology.